Bernard Arnault is outpacing Elon Musk and Mark Zuckerberg in wealth gain this year after signs of a rebound in luxury demand boosted LVMH stock.

LVMH has reclaimed its spot as the biggest company in Europe, overtaking Novo Nordisk after a significant drop in the drugmaker's shares. The cause? Concerns that the US governmen

US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.

The LVMH CEO is now the world's fourth richest ... He leapfrogged Oracle cofounder Larry Ellison on Thursday to take fourth place on Bloomberg's rich list with an estimated $190 billion fortune ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

The net worth of the six richest people in the crowd at Donald Trump's inauguration is roughly equal to a third of the value of the entire UK economy.

An investor group is mounting an eleventh-hour $13.5 billion offer for Paramount, claiming it is superior to the Larry Ellison-backed Skydance deal.

LVMH Moët Hennessy Louis Vuitton CEO Bernard Arnault added around $22.9 billion to his net worth in this year's Bloomberg Billionaires Index.

Billionaires like Elon Musk and Jeff Bezos owe their success to prestigious universities, shaping their paths through innovation and education.

Following Quang's removal, Vietnam had only five billionaires on the Forbes list as of January 24, 2025, with a combined net worth exceeding $12 billion. Pham Nhat Vuong, chairman of Vingroup, continues to lead the pack as the wealthiest Vietnamese billionaire, with a net worth of $4.1 billion.

MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to represent a sustainable long-term revenue generator.

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.